Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Search Results 1-10 of 61 for chemoprevention
Breast cancer chemoprevention: Medicines that reduce breast cancer risk - Mayo Clinic Breast cancer chemoprevention: Medicines that reduce breast cancer risk Print Sections Breast cancer chemoprevention...
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer - Mayo Clinic Overview Tab Title Description Study type Interventional Study phase II Study IDs Study type Interventional Describes the nature of a clinical study.
Chemoprevention - Barrett's Esophagus Lab: Kenneth K.
Limburg's clinical and research interests are focused on chronic disease prevention, with specific emphases on chemoprevention, molecular epidemiology and early detection.
Cancer risk reduction, including chemoprevention, tobacco control and cancer early-detection research In 2003, program leaders Paul J.
Wang Programs Therapeutics Ablative therapies Endoscopic mucosal resection Photodynamic therapy Chemoprevention Biomarkers and imaging ART-00059101
Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic Overview Tab Title Description Study type Inte...
The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will culminate in launching chemoprevention trials at Mayo.
Study IDs Site IRB Rochester, Minnesota: 18-001967 Jacksonville, Florida: 18-001967 Sponsor Protocol Number: 18-001967 About this study The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker ...
Pruthi has been the principal investigator at Mayo Clinic for several nationwide multicenter breast cancer chemoprevention trials; these are interdisciplinary efforts with the Mayo Clinic Cancer Center.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.